Justin L. Lockman

OVERVIEW: What every practitioner needs to know Are you sure your patient has neuroleptic malignant syndrome? What are the typical findings for this syndrome? Neuroleptic Malignant Syndrome (NMS), a life-threatening adverse reaction to anti-dopaminergic (D2 antagonist) drugs, is characterized by fever, rigidity, and mental status changes. Although this syndrome has been characterized as an idiosyncratic…